Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Shares Issued (2023 - 2025)

Camp4 Therapeutics' Shares Issued history spans 3 years, with the latest figure at $25.0 million for Q4 2025.

  • For Q4 2025, Shares Issued changed N/A year-over-year to $25.0 million; the TTM value through Dec 2025 reached $57.5 million, changed N/A, while the annual FY2025 figure was $57.5 million, N/A changed from the prior year.
  • Shares Issued for Q4 2025 was $25.0 million at Camp4 Therapeutics, down from $32.6 million in the prior quarter.
  • Across five years, Shares Issued topped out at $32.6 million in Q3 2025 and bottomed at -$12000.0 in Q4 2023.
  • The 3-year median for Shares Issued is $2000.0 (2024), against an average of $11.5 million.
  • The largest YoY upside for Shares Issued was 1628200.0% in 2025 against a maximum downside of 1628200.0% in 2025.
  • A 3-year view of Shares Issued shows it stood at -$12000.0 in 2023, then skyrocketed by 83.33% to -$2000.0 in 2024, then soared by 1247800.0% to $25.0 million in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Shares Issued are $25.0 million (Q4 2025), $32.6 million (Q3 2025), and -$2000.0 (Q3 2024).